z-logo
open-access-imgOpen Access
Bmi1 Regulates IκBα Degradation via Association with the SCF Complex
Author(s) -
Yuko Okuyama,
Yuki Tanaka,
JingJing Jiang,
Daisuke Kamimura,
Akihiro Nakamura,
Mitsutoshi Ota,
Takuto Ohki,
Daisuke Higo,
Hideki Ogura,
Naoto Ishii,
Toru Atsumi,
Masaaki Murakami
Publication year - 2018
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1701223
Subject(s) - degradation (telecommunications) , bmi1 , association (psychology) , chemistry , cancer research , microbiology and biotechnology , psychology , medicine , computer science , biology , stem cell , psychotherapist , telecommunications
Bmi1 is a polycomb group protein and regulator that stabilizes the ubiquitination complex PRC1 in the nucleus with no evidently direct link to the NF-κB pathway. In this study, we report a novel function of Bmi1: its regulation of IκBα ubiquitination in the cytoplasm. A deficiency of Bmi1 inhibited NF-κB-mediated gene expression in vitro and a NF-κB-mediated mouse model of arthritis in vivo. Mechanistic analysis showed that Bmi1 associated with the SCF ubiquitination complex via its N terminus and with phosphorylation by an IKKα/β-dependent pathway, leading to the ubiquitination of IκBα. These effects on NF-κB-related inflammation suggest Bmi1 in the SCF complex is a potential therapeutic target for various diseases and disorders, including autoimmune diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom